InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Yarema Kristin, Directeur Commercial. Insider active across 4 companies, notably Atara Biotherapeutics, Inc.. In total, 10 disclosures have been logged. Breakdown: 1 buy · 1 sell. Total volume traded: €33k. Activity tracked since 18 May 2021. The latest transaction was filed on 14 August 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Yarema Kristin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
254,800 shares0Common StockSEC:0001803794-26-000003:0
38,376 shares0Common StockSEC:0001803794-26-000002:0
115,129 shares0Common StockSEC:0001803794-26-000002:1
85,400 shares0Common StockSEC:0001803794-26-000001:0
615,836 sharesCommon StockSEC:0001415889-25-001080:0
250,000 shares0Common StockSEC:0000950170-24-001835:0
356,836 shares0Common StockSEC:0001209191-23-024103:0
45,533 shares0Common StockSEC:0001140361-22-007766:0
2,021 shares@ US$14.5072.7% of flowCommon StockSEC:0001567619-21-012110:0
Canonical exit: 9 Sept 2021 (T+90)
761 shares@ US$14.5527.3% of flowCommon StockSEC:0001209191-21-034422:0
10 of 10 declarations
About Yarema Kristin
Yarema Kristin is Directeur Commercial. There are 9 filings in total, and, across the sampled recent filings, the buy and sell amounts are EUR 24074 and EUR 9058, with transactions dated from 2021-05-20 to 2026-07-28. The recent filings also mention ImageneBio, Inc., Poseida Therapeutics, Inc., and Atara Biotherapeutics, Inc.
